The discussion centers on addressing facial changes, often termed "Ozempic face," that result from rapid weight loss due to GLP-1 agonist medications like Ozempic, Mounjaro, Zepbound, and Wegovy. These changes typically involve volume loss in the cheeks and sagging skin. Solutions for restoring facial volume include hyaluronic acid fillers, new fillers that stimulate natural fat production, and platelet-rich plasma (PRP) derived from the patient's own blood. To combat sagging skin, various non-surgical devices are available, such as radiofrequency and ultrasound technologies, which help tighten the skin. These methods aim to mitigate the aesthetic side effects of significant weight loss, allowing individuals to improve their appearance while using these medications.